During 2019, melanoma research continued its rapid pace of advancement, with FDA approval of a new adjuvant therapy treatment option, several first-in-human…
January 8, 2020: The death rate from cancer in the US declined by 29% from 1991 to 2017, including a 2.2% drop…
In October 2015 I ran the Chicago Marathon with my wife, my sisters and my brother-in-law. I had run a few marathons…
NCI Press Release: Posted: August 20, 2018 In a new study, researchers developed a gene expression predictor that can indicate whether melanoma…
Melanoma News Today: Therapies that target elements of the immune system or certain pathways active in cancer cells, in combination with radiation…
NC STATE UNIVERSITY NEWS: Biomedical engineering researchers at North Carolina State University and the University of North Carolina at Chapel Hill have…
Stanley Sher of Washington, D.C. was diagnosed with an aggressive form of melanoma in 2013. After several failed treatments and surgeries, he…
Patients with operable stage III melanoma can now receive the immunotherapy drug ipilimumab (Yervoy®) as adjuvant therapy to help prevent recurrence of…
